You are currently viewing a new version of our website. To view the old version click .

Porcine Vaccines: Enhancing Health, Productivity, and Welfare

This special issue belongs to the section “Veterinary Vaccines“.

Special Issue Information

Dear Colleagues,

We are delighted to invite you to submit your next publication to the journal Vaccines for a Special Issue entitled “Porcine Vaccines: Enhancing Health, Productivity, and Welfare”. Porcine reproductive and respiratory syndrome, porcine viral diarrhea, African swine fever, circovirus-related diseases, and others, seriously harm and restrict the healthy development of the pig industry. In recent years, many variants of porcine viruses have emerged and immunologically escaped from the current available vaccines, causing new challenges in the prevention of porcine diseases and required the updating of existing vaccines, antigens, or adjuvants. DIVA vaccines, multivalent vaccines, and antigen-precise-designed vaccines are the focus of current porcine vaccine research. In addition, oral, spray, and other needle-free vaccination delivery methods have seen strong demand for animal disease control in the future.

This Special Issue will focus on porcine vaccines, including vaccine design, development, effect evaluation, small-animal replacement models, DIVA, vaccination delivery methods, and so on. Original research articles, and comprehensive reviews are welcome. We look forward to receiving your contributions.

Prof. Dr. Tongqing An
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X